0001209191-21-022923.txt : 20210324
0001209191-21-022923.hdr.sgml : 20210324
20210324181100
ACCESSION NUMBER: 0001209191-21-022923
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20210318
FILED AS OF DATE: 20210324
DATE AS OF CHANGE: 20210324
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Shah Chhaya
CENTRAL INDEX KEY: 0001852541
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35726
FILM NUMBER: 21769440
MAIL ADDRESS:
STREET 1: 22 BOSTON WHARF ROAD
STREET 2: 7TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02210
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Radius Health, Inc.
CENTRAL INDEX KEY: 0001428522
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 800145732
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ATTN: CHIEF FINANCIAL OFFICER
STREET 2: 950 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 617-551-4000
MAIL ADDRESS:
STREET 1: ATTN: CHIEF FINANCIAL OFFICER
STREET 2: 950 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
FORMER COMPANY:
FORMER CONFORMED NAME: MPM ACQUISITION CORP
DATE OF NAME CHANGE: 20080228
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2021-03-18
0
0001428522
Radius Health, Inc.
RDUS
0001852541
Shah Chhaya
C/O RADIUS HEALTH, INC.
22 BOSTON WHARF ROAD, 7TH FLOOR
BOSTON
MA
02210
0
1
0
0
Chief Business Officer
Common Stock
19645
D
Stock Option (Right to Buy)
28.74
2028-07-16
Common Stock
60000
D
Stock Option (Right to Buy)
19.18
2029-02-22
Common Stock
30000
D
Stock Option (Right to Buy)
19.96
2030-02-20
Common Stock
20000
D
Stock Option (Right to Buy)
14.08
2030-11-09
Common Stock
15000
D
Stock Option (Right to Buy)
18.60
2031-02-22
Common Stock
35000
D
25% of the shares subject to this stock option vested on July 16, 2019; and the remaining shares have vested or shall vest in substantially equal monthly installments over 36 months thereafter.
25% of the shares subject to this stock option vested on February 22, 2020; and the remaining shares have vested or shall vest in substantially equal monthly installments over 36 months thereafter.
25% of the shares subject to this stock option vested on February 20, 2021; and the remaining shares have vested or shall vest in substantially equal monthly installments over 36 months thereafter.
25% of the shares subject to this stock option shall vest on November 9, 2021; and the remaining shares shall vest in substantially equal monthly installments over 36 months thereafter.
25% of the shares subject to this stock option shall vest on February 22, 2022; and the remaining shares shall vest in substantially equal monthly installments over 36 months thereafter.
/s/ Averi Price, as attorney-in-fact
2021-03-24
EX-24.3_975377
2
poa.txt
POA DOCUMENT
LIMITED POWER OF ATTORNEY
The undersigned hereby constitutes and appoints G. Kelly Martin, Averi Price,
James Chopas, and Nathan McConarty, and each of them individually, with full
power of substitution, as the undersigneds true and lawful attorney-in-fact to:
(1) prepare, execute in the undersigneds name and on the undersigneds behalf,
and submit to the U.S. Securities and Exchange Commission (the "SEC") a Form ID,
including amendments thereto, and any other documents necessary or appropriate
to obtain codes and passwords enabling the undersigned to make electronic
filings with the SEC of reports required by Section 16(a) of the Securities
Exchange Act of 1934, as amended, or any rule or regulation of the SEC;
(2) execute for and on behalf of the undersigned, in the undersigneds capacity
as officer and/or director of Radius Health, Inc. (the "Company"), Forms 3, 4, 5
and any Schedules 13D or 13G in accordance with Section 16(a) of the Securities
Exchange Act of 1934, as amended, and the rules thereunder;
(3) do and perform any and all acts for and on behalf of the undersigned that
may be necessary or desirable to complete and execute any such Form 3, 4, or 5
or Schedule 13D or 13G, complete and execute any amendment or amendments
thereto, and timely file such form with the SEC and any stock exchange or
similar authority; and
(4) take any other action of any type whatsoever in connection with the
foregoing that, in the opinion of each such attorney-in-fact, may be of benefit
to, in the best interest of, or legally required by, the undersigned, it being
understood that the documents executed by each such attorney-in-fact on behalf
of the undersigned pursuant to this Power of Attorney shall be in such form and
shall contain such terms and conditions as each such attorney-in-fact may
approve in each such attorney-in-facts discretion.
The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary, or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that each such attorney-in-fact, or each
such attorney-in-facts substitute or substitutes, shall lawfully do or cause to
be done by virtue of this power of attorney and the rights and powers herein
granted. The undersigned acknowledges that each foregoing attorney-in-fact, in
serving in such capacity at the request of the undersigned, are not assuming,
nor is the Company assuming, any of the undersigneds responsibilities to comply
with Section 16 of the Securities Exchange Act of 1934, as amended.
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4, 5, and any Schedules 13D
or 13G with respect to the undersigneds holdings of and transactions in
securities issued by the Company, unless earlier revoked by the undersigned in a
signed writing delivered to each foregoing attorney-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of March 17th, 2021.
Signature: /s/ Chhaya Shah
Name: Chhaya Shah